Last C$0.02 CAD
Change Today 0.00 / 0.00%
Volume 7.5K
PYT On Other Exchanges
As of 11:25 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

pyng medical corp (PYT) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/13/14 - C$0.07
52 Week Low
11/20/14 - C$0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PYNG MEDICAL CORP (PYT)

Related News

No related news articles were found.

pyng medical corp (PYT) Related Businessweek News

No Related Businessweek News Found

pyng medical corp (PYT) Details

Pyng Medical Corp., a medical device company, discovers, develops, manufactures, and markets a suite of trauma and resuscitation products. The company’s products include FAST1, an intraosseous infusion system that provides lifesaving vascular access to enable the administration of drugs, medications, fluids, and blood to patients that require emergency treatment, as well as used in the sternum during adult and adolescent emergency intervention. It also offers FASTx, a sternal intraosseous device that delivers emergency fluids and medications into the vascular system through the bone marrow of the manubrium; MAT Tourniquet that saves limbs and lives by providing complete arterial occlusion with one-handed operation; and T-POD Pelvic Stabilizer for the treatment of pelvic trauma, pain, and bleed-out while preventing loss of life. In addition, the company provides CRIC Cricothyroidotomy System that incorporates necessary instruments, including a depth-controlled scalpel—for establishing an airway in civilian or military casualties suffering from facial, jaw, and upper-neck injuries. It sells its products directly and through distribution partners to military, hospitals, emergency medical services, government agencies, and law enforcement customers. Pyng Medical Corp. is headquartered in Richmond, Canada.

pyng medical corp (PYT) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: C$193.2K
Chief Financial Officer and Corporate Secreta...
Total Annual Compensation: C$120.5K
Compensation as of Fiscal Year 2013.

pyng medical corp (PYT) Key Developments

Pyng Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014

Pyng Medical Corp. reported earnings results for the third quarter and nine months ended June 30, 2014. The company reported total sales of $947,772 for the three months ended June 30, 2014, down 27% compared with $1,294,369 for the comparative quarter last year. The primary reason for this decline was that FAST1 sales to the USA Federal Market segment have been front-loaded in fiscal 2014. This front-loading led to strong growth in first quarter and second quarter, but caused third quarter revenues to decline as military inventories needed to come down. A net loss of $181,931 was reported for the quarter, which was slightly higher than $177,905 reported a year ago, equal to loss of $0.01 per share. Earnings before interest, depreciation, amortization and taxes from continuing operations were $32,718, an increase of $28,666 from $4,052 reported for the third quarter of fiscal 2013. For the nine-month period, total sales were $3,951,066, up 19% from $3,330,019 reported for the comparative period last year. Net loss was reduced from $821,968 to $457,386 for the nine-month period of this year. The reduced loss was also attributed to the reduction in research and product development expenses and lower general and administrative expenses, partially offset by expense increases in interest, sales and marketing, and amortization on intangible assets.

Pyng Medical Corp. to Report Q3, 2014 Results on Aug 26, 2014

Pyng Medical Corp. announced that they will report Q3, 2014 results at 12:00 PM, Pacific Standard Time on Aug 26, 2014

Pyng Medical Corp. Signs Seven New Exclusive Specialty Distributors in United States

Pyng Medical Corp. announced the signing of seven new exclusive medical device specialty distributors to market the company's trauma products in the United States. These new distributors already have exclusive rights to market Pyng Medical's FASTResponder Sternal Intraosseous (IO) Device, and now also have exclusive rights to market Pyng's T-PODResponder Pelvic Stabilization Device and MATResponder Tourniquet. The new distributors will serve the USA hospital and pre-hospital markets within designated geographic regions.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PYT:CN C$0.02 CAD 0.00

PYT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PYT.
View Industry Companies

Industry Analysis


Industry Average

Valuation PYT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.1x
Price/Cash Flow 1.7x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PYNG MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at